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Biliary microhamartomas, also known as bile duct hamartomas and von Meyenburg complexes, are benign neoplasms containing
cysticdilatedbileductsembeddedinﬁbrousstroma.Theydevelopinhepatobiliarysystem,donotgenerallygiveclinicaloutcomes,
and are detected incidentally. However, they can rarely show malignant transformation. Our aim was to report the contribution of
computed tomography, routine magnetic resonance imaging, and magnetic resonance cholangiopancreatography in the diagnosis
of biliary microhamartomas in a 61-year-old woman.
1.Introduction
Biliary microhamartomas, also known as bile duct hamar-
tomas and von Meyenburg complexes, develop in hepato-
biliary system and do not generally give clinical outcomes.
They are detected incidentally in most cases. Biliary micro-
hamartomas are focal, disorderly collection of bile ducts that
results from failure of involution of embryonic bile ducts [1].
They are benign neoplasms; however, they can rarely show
malignant transformation [2]. Biliary microhamartomas are
not uncommon. At autopsy, they were found in 5.6% of
adults and in 0.9% of children [3]. Their incidence was
reported as 0.6% in a serie including 2000 consecutive liver
needle biopsies [4]. Our aim was to report the contribution
of computed tomography (CT), routine magnetic resonance
imaging (MRI), and magnetic resonance cholangiopancre-
atography(MRCP)indiagnosisofbiliarymicrohamartomas.
2.CaseReport
A 61-year-old, mildly obese woman with short stature was
referred with right upper quadrant pain. The history of
the patient was unremarkable, and she did not mention
any medical or surgical illness. Laboratory examinations
revealed hemoglobin (Hb): 13.6g/dL, white blood cell
(WBC): 7,100/mm3, serum albumin: 3.7g/dL (N: 3.8–
5.1g/dL), alanine aminotransferase (ALT): 24U/L (N: 0–
31U/L), alkaline phosphatase: 202U/L (N: 0–240U/L),
gamma-glutamyl transferase (GGT): 24 U/L (N: 0–38U/L).
The patient was informed about the imaging procedures,
and consent was obtained from her. All the procedures
were performed according to the World Medical Association
Declaration of Helsinki. Initially, we performed abdominal
u l t r a s o n o g r a p h y( U S ) ,b u tw ew e r eu n a b l et od e m o n s t r a t e
any prominent lesion in liver (Figure 1).
CT,routineMRI,andMRCPwereperformedafterwards.
Contrast-enhanced CT revealed multiple, scattered, small,
hypodense nodular lesions in liver parenchyma, measuring
1.5cm or less in size (Figure 2).
On upper abdominal MRI, multiple, small, nodular
lesions with slightly irregular contours in the liver parenchy-
ma, measuring 1.5cm or less in size, were detected. The
lesions were hypointense on T1-weighted images and hyper-




Figure 2: Contrast-enhanced CT revealed multiple, scattered,
small, hypodense nodular lesions in liver (black arrows).
revealed no restriction of diﬀusionintheliverlesions.MRCP
depicted an abundant number of hyperintense small lesions
allover the liver which showed no association with the
biliary system. The widths and contours of intrahepatic and
extrahepatic bile ducts and pancreatic canal were normal on
MRCP (Figure 3).
Aftermakingadetaileddiﬀerentialdiagnosis,clinicaland
imaging ﬁndings were consistent with biliary microhamar-
tomas, and the patient was included in a follow-up program
to monitor the liver lesions.
3. Discussion
Biliary microhamartomas are tumor-like lesions of the liver
[2]. Histologically, they are clusters of proliferated bile
ducts lined by single layer of cuboidal cells embedded in
ﬁbrocollagenous tissue, and their size varies between 0.1
and 10mm, but lesions measuring 1.5cm in diameter can
be demonstrated, as it was in the present case. Biliary
microhamartomas do not generally give any symptoms
[1, 5]. Adult polycystic liver disease (APLD) was reported
to associate with biliary microhamartomas [1, 6]. With any
imaging modality mentioned above, we could not be able to
demonstrate larger and more numerous liver cysts which we
are used to see in enlarged, diﬀusely cystic livers with APLD.
Butwedecidedtoincludethepatientinafollow-upprogram
to monitor the liver lesions.
US, CT, MRI, MRCP, and hepatobiliary scintigraphy
(HBS) were used as imaging modalities in the diagnosis of
biliary microhamartomas [7–9]. On US, the lesions can be
seenasmultiple,small,hypoechoic,oranechoiccysticlesions
involving all segments. However, besides small cystic lesions,
biliary microhamartomas can also be seen as hyperechogenic
areas or lesions, and comet-tail artifacts may be seen
posteriortothelesions[9,10].Inthepresentcase,USdidnot
reveal any prominent lesion, suggesting that US may not be a
suitable modality to show biliary microhamartomas. On CT,
biliary microhamartomas are observed as multiple, round or
irregular, small, hypodense lesions up to scattered through-
out the liver on precontrast images. Luo et al. reported that
on CT, lesions showed no enhancement, but increased in
number by approximately 80–150% after administration of
intravenous contrast medium [11]. On MRI, lesions appear
hypointense and hyperintense on precontrast T1-weighted
images and T2-weighted images, respectively. They show
no communication with the biliary tree and demonstrate
irregular delineation with no or slight rim enhancement
following gadolinium administration [7].
In diﬀerential diagnosis, it is necessary to consider
peribiliary cysts, simple hepatic cysts, autosomal dominant
polycystic disease, metastatic liver disease, microabscesses,
dilated biliary ducts, and Caroli’s disease [1, 8, 9, 12].
Peribiliary cysts are multiple, small, cystic dilatations of
the intrahepatic extramural peribiliary glands, but they
are located exclusively in the hepatic hilum and along
the larger portal tract [13], which is diﬀerent from the
scattered distribution of biliary microhamartomas. Simple
hepatic cysts are not as numerous and uniformly small as
biliarymicrohamartomas.Inautosomaldominantpolycystic
disease, cysts are usually larger and more numerous. Liver
metastases are more variable in size, density, or signal inten-
sity on CT and MRI [1]. MRI can aid in the diﬀerentiation
of liver cysts (such as biliary microhamartomas) and liver
metastases by identifying the hyperintense signal from liver
cysts on heavily T2-weighted sequences [8]. Diﬀerentia-
tion of biliary microhamartomas from microabscesses can
generally be made clinically. Diﬀerentiation from dilated
biliary ducts and Caroli’s disease can be made by looking
at their association with biliary ducts using MRCP. Nuclear
imaging can also be performed in diﬀerentiation of biliary
microhamartomas from Caroli’s disease. In Caroli’s disease,
HBS shows a particular pattern of cystic dilatation with
accumulation of tracer in the intrahepatic ducts of the
biliary tree [14]. Zheng et al. performed HBS in a case of
biliary microhamartoma by using 99mTC-N-pyridoxy 1-5-
methyltryptophan(99mTC-PMT).HBSrevealedthatbiliary
system excreting function of radioisotope was normal andCase Reports in Medicine 3
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Figure 3: On T1-weighted image of the liver (a), multiple, small, hypointense nodular lesions with slightly irregular contours (white arrows)
are demonstrated, which are hyperintense (b) (white arrows) on T2-weighted image. Diﬀusion-weighted image (c) reveals no restriction of
diﬀusionintheliverlesions.MRCP(d)depictsanabundantnumberofhyperintensesmalllesionsallovertheliverwhichshownoassociation
with the biliary system. The widths and contours of intrahepatic and extrahepatic bile ducts and pancreatic canal are normal.
demonstrated normal appearances of biliary system without
pooling areas [9] which helped to diﬀerentiate the entity
from Caroli’s disease. In our case, since MRCP depicted
bile ducts with their normal width, shape, and contours,
we did not need to perform further imaging with HBS.
We recommend the clinicians to use MRCP as an ultimate
imaging modality to diﬀerentiate biliary microhamartomas
from Caroli’s disease as we did in our case, but whenever
they experience diﬃculty in diagnosis, we suggest that they
can use HBS as a conﬁrmative tool to solve the problem.
In conclusion, CT, MRI, and MRCP were useful in
diﬀerentiating biliary microhamartomas from other cystic
liver diseases and metastatic liver lesions in our case.
Though biliary microhamartomas rarely show malignant
transformation, this probability make radiological imaging
of biliary microhamartomas necessary for early diagnosis.
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